MECLIZINE HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

meclizine hydrochloride tablet

direct_rx - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system. meclizine hydrochloride tablets are contraindicated in individuals who have shown a previous hypersensitivity to it.

MECLIZINE HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

meclizine hydrochloride tablet

direct_rx - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system. meclizine hydrochloride tablets are contraindicated in individuals who have shown a previous hypersensitivity to it.

MECLIZINE HYDROCHLORIDE- meclizine hydrochloride tablet United States - English - NLM (National Library of Medicine)

meclizine hydrochloride- meclizine hydrochloride tablet

remedyrepack inc. - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system. meclizine hydrochloride tablets are contraindicated in individuals who have shown a previous hypersensitivity to it.

MECLIZINE HYDROCHLORIDE- meclizine hydrochloride tablet United States - English - NLM (National Library of Medicine)

meclizine hydrochloride- meclizine hydrochloride tablet

remedyrepack inc. - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system. meclizine hydrochloride tablets are contraindicated in individuals who have shown a previous hypersensitivity to it.

MECLIZINE HCL 12.5 MG tablet United States - English - NLM (National Library of Medicine)

meclizine hcl 12.5 mg tablet

reliable 1 laboratories llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride 12.5 mg - antiemetic - prevents and treats nausea, vomiting, or dizziness due to motion sickness - for other uses, consult your doctor

MECLIZINE HCL 12.5 MG tablet United States - English - NLM (National Library of Medicine)

meclizine hcl 12.5 mg tablet

bryant ranch prepack - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride 12.5 mg - antiemetic - prevents and treats nausea, vomiting, or dizziness due to motion sickness - for other uses, consult your doctor

MECLIZINE HCL 25 MG- meclizine hydrochloride tablet, chewable United States - English - NLM (National Library of Medicine)

meclizine hcl 25 mg- meclizine hydrochloride tablet, chewable

proficient rx lp - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride 25 mg - antiemetic prevents and treats nausea, vomiting or dizziness due to motion sickness do not use in children under 12 years of age unless directed by a doctor.

MECLIZINE HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

meclizine hydrochloride tablet

direct_rx - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. meclizine hydrochloride tablets are contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients [see adverse reactions (6) and description (11)]. 7.1 cns depressants there may be increased cns depression when meclizine hydrochloride is administered concurrently with other cns depressants, including alcohol [see warnings and precautions (5.1)]. 7.2 cyp2d6 inhibitors based on in-vitro evaluation, meclizine is metabolized by cyp2d6. therefore, there is a possibility for a drug interaction between meclizine hydrochloride and cyp2d6 inhibitors. therefore, monitor for adverse reactions and clinical effect accordingly.

MECLIZINE HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

meclizine hydrochloride tablet

direct_rx - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. meclizine hydrochloride tablets are contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients [see adverse reactions (6) and description (11)]. 8.1 pregnancy risk summary data from epidemiological studies have not generally indicated a drug-associated risk of major birth defects with meclizine during pregnancy. however, in a published study, an increased incidence of fetal malformations was observed following oral administration of meclizine to pregnant rats during the period of organogenesis, at doses similar to those used clinically. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. data human data e

MECLIZINE HYDROCHLORIDE tablet
MECLIZINE HYDROCHLORIDE tablet, chewable United States - English - NLM (National Library of Medicine)

meclizine hydrochloride tablet meclizine hydrochloride tablet, chewable

nortic pharma, llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. meclizine hydrochloride is contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients [see adverse reactions (6) and description (11)] . risk summary data from epidemiological studies have not generally indicated a drug-associated risk of major birth defects with meclizine during pregnancy. however, in a published study, an increased incidence of fetal malformations was observed following oral administration of meclizine to pregnant rats during the period of organogenesis, at doses similar to those used clinically. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. data human data epidemiological studies